Real-world data show a rise in biomarker testing for primary advanced/recurrent endometrial cancer, especially mismatch repair/microsatellite instability, but disparities in access persist across care...
In this interview, Jeffrey Levine, MD, MPH, previews his Practical Updates in Primary Care 2025 presentation on managing menopause across life stages. He discusses the impact of hormonal changes on mental...
A new study from Mayo Clinic and Exact Sciences demonstrates that a six-gene methylated DNA marker panel, detectable in vaginal fluid, accurately identifies endometrial cancer in women with abnormal uterine...
A retrospective cohort study found that endometrial biopsies identifying endometrial intraepithelial neoplasia were associated with a higher likelihood of endometrial cancer and high-risk features on final...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
Researchers set out to determine whether short-course vaginal cuff brachytherapy regimen maintains quality of life and acceptable toxicity in patients with early-stage endometrial cancer.
A multicenter study revealed significant variations in the administration of postpartum venous thromboembolism (VTE) prophylaxis and highlighted key risk factors influencing its use.
A phase 3 trial subgroup analysis found that adding pembrolizumab to adjuvant chemotherapy may improve disease-free survival in patients with mismatch repair-deficient endometrial cancer, a population at...
A randomized trial found that radiation therapy alone provides better progression-free survival and fewer acute toxicities than chemoradiation for women with localized recurrent endometrial cancer.
A new study outlines key barriers and facilitators to adopting a clinical practice guideline aimed at improving perinatal pain management and identifies strategies and tools to support implementation in...
